SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yasuo Takeuchi, Emiko Takeuchi, Takashi Ishida, Masafumi Onodera, Hiromitsu Nakauchi, Makoto Otsu, Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease, International Journal of Hematology, 2015, 102, 1, 111

    CrossRef

  2. 2
    T. Bakchoul, U. J. Sachs, Platelet destruction in immune thrombocytopenia, Hämostaseologie, 2015, 35, 3

    CrossRef

  3. 3
    Raymond S. M. Wong, Kalpana Bakshi, Andres Brainsky, Thrombophilia in patients with chronic immune thrombocytopenia, Scandinavian Journal of Clinical and Laboratory Investigation, 2015, 75, 1, 13

    CrossRef

  4. 4
    Andrew Shih, Ishac Nazi, John G. Kelton, Donald M. Arnold, Novel treatments for immune thrombocytopenia, La Presse Médicale, 2014, 43, 4, e87

    CrossRef

  5. 5
    S. Audia, M. Rossato, K. Santegoets, S. Spijkers, C. Wichers, C. Bekker, A. Bloem, L. Boon, T. Flinsenberg, E. Compeer, T. van den Broek, O. Facy, P. Ortega-Deballon, S. Berthier, V. Leguy-Seguin, L. Martin, M. Ciudad, M. Samson, M. Trad, B. Lorcerie, N. Janikashvili, P. Saas, B. Bonnotte, T. R. D. J. Radstake, Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia, Blood, 2014, 124, 18, 2858

    CrossRef

  6. 6
    M. Pant, P.S. Acharya, V.R. Bhatt, P.T. Silberstein, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  7. 7
    Lucienne Chatenoud, The Autoimmune Diseases, 2014,

    CrossRef

  8. 8
    Michael Croft, Chris A. Benedict, Carl F. Ware, Clinical targeting of the TNF and TNFR superfamilies, Nature Reviews Drug Discovery, 2013, 12, 2, 147

    CrossRef

  9. 9
    C. E. Neunert, Current management of immune thrombocytopenia, Hematology, 2013, 2013, 1, 276

    CrossRef

  10. 10
    M. N. Saleh, J. B. Bussel, G. Cheng, O. Meyer, C. K. Bailey, M. Arning, A. Brainsky, Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study, Blood, 2013, 121, 3, 537

    CrossRef

  11. 11
    P. Anoop, Immune thrombocytopenic purpura: Historical perspective, current status, recent advances and future directions, Indian Pediatrics, 2012, 49, 10, 811

    CrossRef

  12. 12
    Nichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, Ethel Cesarman, Janice G. McFarland, James B. Bussel, Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia, British Journal of Haematology, 2012, 158, 4
  13. 13
    Mindy S. Lo, George C. Tsokos, Treatment of systemic lupus erythematosus: new advances in targeted therapy, Annals of the New York Academy of Sciences, 2012, 1247, 1
  14. 14
    Roberto Stasi, Adrian C. Newland, ITP: a historical perspective, British Journal of Haematology, 2011, 153, 4
  15. 15
    S. Audia, B. Lorcerie, B. Godeau, B. Bonnotte, Physiopathologie du purpura thrombopénique immunologique, La Revue de Médecine Interne, 2011, 32, 6, 350

    CrossRef

  16. 16
    Nathan J. Felix, Anish Suri, Luisa Salter-Cid, Steven G. Nadler, Sheila Gujrathi, Michael Corbo, Richard Aranda, Targeting lymphocyte co-stimulation: From bench to bedside, Autoimmunity, 2010, 43, 7, 514

    CrossRef

  17. 17
    Trevor T. Hansel, Harald Kropshofer, Thomas Singer, Jane A. Mitchell, Andrew J. T. George, The safety and side effects of monoclonal antibodies, Nature Reviews Drug Discovery, 2010, 9, 4, 325

    CrossRef

  18. 18
    Bertrand Godeau, Marc Michel, Treatment of chronic immune thrombocytopenic purpura in adults, Annals of Hematology, 2010, 89, S1, 55

    CrossRef

  19. 19
    Anna L. Peters, Laura L. Stunz, Gail A. Bishop, CD40 and autoimmunity: The dark side of a great activator, Seminars in Immunology, 2009, 21, 5, 293

    CrossRef

  20. 20
    Alan T Nurden, Jean-François Viallard, Paquita Nurden, New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura, The Lancet, 2009, 373, 9674, 1562

    CrossRef

  21. 21
    C. Hu, F. S. Wong, L. Wen, Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases, Clinical & Experimental Immunology, 2009, 157, 2
  22. 22
    M. C. Levesque, Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders, Clinical & Experimental Immunology, 2009, 157, 2
  23. 23
    Felix Braun, Thomas Becker, Lutz Renders, Burckhardt Ringe, Immunosuppressive Drugs, eLS,
  24. 24
    Frank R. Brennan, T Cell Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders,